Requirement of transcription factor AML1 in proliferation of developing thymocytes

被引:15
作者
Sato, T
Ito, R
Nunomura, S
Ohno, S
Hayashi, K
Satake, M
Habu, S
机构
[1] Tokai Univ, Sch Med, Dept Immunol, Isehara, Kanagawa 2591193, Japan
[2] Tokai Univ, Sch Med, Inst Glycotechnol, Isehara, Kanagawa 2591193, Japan
[3] Tohoku Univ, Dept Mol Immunol, Inst Dev Aging & Canc, Aoba Ku, Seiryo, Sendai 9808575, Japan
关键词
thymocyte; differentiation; AML1; Runx; reaggregation culture; proliferation;
D O I
10.1016/S0165-2478(03)00103-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although the transcription factor AML1/Runx1 is known to be essential for definitive hematopoiesis, its role in T cell differentiation is not well understood. In this study, we investigated the functions of AML1 in the early stage of thymocyte differentiation. For this, we crossed AML1 dominant interfering form (Runt)-transgenic mice with TCR-transgenic mice, and demonstrated the decrease of CD4(+)8(+) (DP) thymocyte cell number although their proportion was not reduced. Reaggregation culture system for thymocytes of (Runt x TCR) double transgenic mice, in which the rate of de novo transition from DN cells to the DP stage can be estimated, showed that the cell division during the DN-to-DP transition is impaired without significant cell death. These results indicate that AMLI is involved in thymocyte differentiation by controlling cell proliferation. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 25 条
  • [1] AML1 stimulates G1 to S progression via its transactivation domain
    Bernardin, F
    Friedman, AD
    [J]. ONCOGENE, 2002, 21 (20) : 3247 - 3252
  • [2] Dichotomy of AML1-ETO functions: Growth arrest versus block of differentiation
    Burel, SA
    Harakawa, N
    Zhou, LM
    Pabst, T
    Tenen, DG
    Zhang, DE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (16) : 5577 - 5590
  • [3] Early growth response transcription factors are required for development of CD4-CD8- thymocytes to the CD4+CD8+ stage
    Carleton, M
    Haks, MC
    Smeele, SAA
    Jones, A
    Belkowski, SM
    Berger, MA
    Linsley, P
    Kruisbeek, AM
    Wiest, DL
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (04) : 1649 - 1658
  • [4] Defining the specific physiological requirements for c-Myc in T cell development
    Douglas, NC
    Jacobs, H
    Bothwell, ALM
    Hayday, AC
    [J]. NATURE IMMUNOLOGY, 2001, 2 (04) : 307 - 315
  • [5] FUSION OF THE TEL GENE ON 12P13 TO THE AML1 GENE ON 21Q22 IN ACUTE LYMPHOBLASTIC-LEUKEMIA
    GOLUB, TR
    BARKER, GF
    BOHLANDER, SK
    HIEBERT, SW
    WARD, DC
    BRAYWARD, P
    MORGAN, E
    RAIMONDI, SC
    ROWLEY, JD
    GILLILAND, DG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) : 4917 - 4921
  • [6] A ROLE FOR A PRE-T-CELL RECEPTOR IN T-CELL DEVELOPMENT
    GROETTRUP, M
    VONBOEHMER, H
    [J]. IMMUNOLOGY TODAY, 1993, 14 (12): : 610 - 614
  • [7] Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells
    Hayashi, K
    Natsume, W
    Watanabe, T
    Abe, N
    Iwai, N
    Okada, H
    Ito, Y
    Asano, M
    Iwakura, Y
    Habu, S
    Takahama, Y
    Satake, M
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (12) : 6816 - 6824
  • [8] Dimerization with PEBP2β protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation
    Huang, G
    Shigesada, K
    Ito, K
    Wee, HJ
    Yokomizo, T
    Ito, Y
    [J]. EMBO JOURNAL, 2001, 20 (04) : 723 - 733
  • [9] STUDIES ON T-CELL MATURATION ON DEFINED THYMIC STROMAL CELL-POPULATIONS INVITRO
    JENKINSON, EJ
    ANDERSON, G
    OWEN, JJT
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (03) : 845 - 853
  • [10] GENERATION OF THE AML1-EVI-1 FUSION GENE IN THE T(3 21)(Q26 Q22) CAUSES BLASTIC CRISIS IN CHRONIC MYELOCYTIC-LEUKEMIA
    MITANI, K
    OGAWA, S
    TANAKA, T
    MIYOSHI, H
    KUROKAWA, M
    MANO, H
    YAZAKI, Y
    OHKI, M
    HIRAI, H
    [J]. EMBO JOURNAL, 1994, 13 (03) : 504 - 510